Inventor · disambiguated record
Guanghuai Zeng
Also filed as: ZENG GUANGHUAI
8 granted patents·2 pending applications·12 citations·filing 2010–2023
79Inventor score
Files withTIANJIN HEMAY PHARMACEUTICAL SCI TECH CO LTD3TIANJIN HEMAY BIO TECH CO LTD2TIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO LTD2GANZHOU HEMAY PHARMACEUTICAL CO LTD1TIANJIN HEMAY PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
10 records- 0185US8952178B2Thiophene derivativesZHANG HESHENG·Filed 2010·Granted Feb 10, 2015·10 cites·22 claims
- 0274US12331030B2Piperidine-2,6-dione derivatives and ulcerative colitis treatingTIANJIN HEMAY PHARMACEUTICAL SCI TECH CO LTD·Filed 2023·Granted Jun 17, 2025·0 cites·30 claims
- 0373US9630975B2Thiophene derivativesTIANJIN HEMAY BIO-TECH CO LTD·Filed 2014·Granted Apr 25, 2017·2 cites·14 claims
- 0471US11873287B2Piperidine-2,6-dione derivatives and ulcerative colitis treatingTIANJIN HEMAY PHARMACEUTICAL SCI TECH CO LTD·Filed 2022·Granted Jan 16, 2024·0 cites·14 claims
- 0561US10611775B2Thiophene derivativesTIANJIN HEMAY PHARMACEUTICAL CO LTD·Filed 2019·Granted Apr 7, 2020·0 cites·14 claims
- 0659US11485724B2Piperidine-2,6-dione derivatives and ulcerative colitis treatingTIANJIN HEMAY PHARMACEUTICAL SCI TECH CO LTD·Filed 2017·Granted Nov 1, 2022·0 cites·8 claims
- 0757US9840494B2Quinazoline derivativeTIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO LTD·Filed 2014·Granted Dec 12, 2017·0 cites·13 claims
- 0856US2025325676A1Camptothecin prodrug and pharmaceutical composition thereofTIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0953US10385062B2Thiophene derivativesTIANJIN HEMAY BIO TECH CO LTD·Filed 2017·Granted Aug 20, 2019·0 cites·14 claims
- 1053US2025074918A1Thiophene derivatives preparingGANZHOU HEMAY PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Guanghuai Zeng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →